English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduLGBTQ+ people may be more likely to have negative brain health outcomes, including a higher risk of dementia and late-life depression, than people who are cisgender and straight, according to a study published in the September 25, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. These results do not prove that sexual or gender diversity causes neurological diseases, they only show an association.
Tag: Neurological Diseases
Two-stage computer algorithm will detect epilepsy with high precision
Scientists elaborated algorithm that much better detects epilepsy on EEG recordings, than other automated methods. To achieve this, authors combined two approaches to analysis of signals of brain activity – classifier, that doesn’t require education, and trainable neural network. The project will enable to automate analysis of EEG and so simplify the process of detecting of epilepsy. Results of the research, supported by the grant of Presidential program of Russian Scientific Foundation, are published in the magazine IEEE Access.
Study reveals racial disparities in Huntington’s disease diagnoses
New research led by UCLA Health revealed that Black patients with Huntington’s disease in the U.S. and Canada received their diagnoses, on average, one year later compared to White patients after symptoms first appear.
Hahn Awarded CZI Grant to Monitor, Manipulate Proteins Important in Nervous System Function, Neurological Disease
Klaus Hahn, PhD, the Ronald G. Thurman Distinguished Professor of Pharmacology at the UNC School of Medicine, will co-lead this Chan Zuckerberg Initiative project with colleagues at Duke University and North Carolina State University.
‘Carb’ Treatment for Stroke Receives New U.S. Patent
A new twist on a drug used to treat alcohol use disorder could double up as a treatment for stroke. Called “Carb” for short, this new formulation is designed to treat ischemic stroke, protect brain tissue against injury and minimize the size of a brain infarct.
Harnessing good fats to relieve MS symptoms
Researchers find that fish oil derivative reduces and delays disease–causing inflammation in mouse model of multiple sclerosis
Stimulating axon re-growth after spinal cord injury
A new study by Burke Neurological Institute (BNI), Weill Cornell Medicine, finds that activation of MAP2K signaling by genetic engineering or non-invasive repetitive transcranial magnetic stimulation (rTMS) promotes corticospinal tract (CST) axon sprouting and functional regeneration after spinal cord injury (SCI) in mice.
University of Washington joins industry-academia alliance to accelerate research in neuroscience
The University of Washington has joined the Alliance for Therapies in Neuroscience (ATN), a long-term research partnership between UC San Francisco, UC Berkeley, Genentech (a member of the Roche group) and Roche Holding AG geared to transform the fight against brain diseases and disorders of the central nervous system.
‘Eye-catching’ smartphone app could make it easy to screen for neurological disease at home
UC San Diego researchers developed a smartphone app that could allow people to screen for Alzheimer’s disease, ADHD and other neurological diseases and disorders—by recording closeups of their eye. The app uses a smartphone’s built-in near-infrared camera and selfie camera to track how a person’s pupil changes in size. These pupil measurements could be used to assess a person’s cognitive condition.
Researchers find evidence of protein folding at site of intracellular droplets
Researchers at Notre Dame found that elevated concentrations of proteins within the droplets triggered a folding event, increasing the potential for protein aggregation — or misfolding — which has been linked to neurological diseases including Alzheimer’s disease and ALS.
Microvention Funds $250,000 Educational Grant for the Advancement of Endovascular Education and Technology to the CNS Foundation
MicroVention, one of the world’s fastest growing medical device companies, has granted $250,000 to the Congress of Neurological Surgeons Foundation (CNS Foundation). This generous gift will fund educational programs dedicated toward the advancement of the field of endovascular education and technology.